• No results found

University of Groningen Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine Alexandra

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine Alexandra"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Improving quality of care for patients with ovarian and endometrial cancer

Eggink, Florine Alexandra

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Eggink, F. A. (2018). Improving quality of care for patients with ovarian and endometrial cancer.

Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Improving

quality

of

care

for

patients

with

ovarian

and

endometrial cancer

(3)

Eggink, Florine Alexandra

Improving quality of care for patients with ovarian and endometrial cancer

PhD dissertation, University of Groningen, The Netherlands

ISBN electronic: 978-94-034-0283-3

ISBN printed: 978-94-034-0284-0

© Copyright 2017- Florine Eggink, Groningen, The Netherlands.

All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system or transmitted in any form or by any means, without prior permission of the author or, when appropriate, the publisher of the published articles.

Cover design and layout: evelienjagtman.com

Printed by: Ridderprint BV

Printing of this thesis was financially supported by the University of Groningen, University Medical Center Groningen, Graduate School of Medical Sciences, Integraal Kankercentrum Nederland, Chipsoft BV, Stichting Olijf and Noord Negentig.

(4)

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 31 januari om 14.30 uur

door

Florine Alexandra Eggink

geboren op 7 september 1987 te Groningen

(5)

Promotores

Prof. dr. H.W. Nijman Prof. dr. R.F.P.M. Kruitwagen

Co-promotores

Dr. M.A. van der Aa Dr. M. de Bruyn

Beoordelingscommissie

Prof. Dr. G.A. Huls Prof. Dr. L.F.A.G. Massuger Prof. Dr. I.J.M. de Vries

Paranimfen

Dr. J.I. Kamstra Drs. F.L. Komdeur

(6)

TABLE OF CONTENTS

Chapter 1 General introduction 9

Part I: Improving organization of care for patients with ovarian cancer

Chapter 2 Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.

Gynecologic Oncology. 2016 Jun;141(3):524-30

21

Chapter 3 The impact of centralization of services on treatment delay in ovarian cancer: a study on process quality.

International Journal for Quality in Health Care. 2017 Oct 1;29(6):810-816

41

Chapter 4 Surgery for patients with newly diagnosed advanced ovarian cancer: which patient, when and extent?

Current Opinion in Oncology. 2017 Sep; 29(5):351-358

57

Part II: Improving organization of care for patients with endometrial cancer Chapter 5 Less favorable prognosis for low risk endometrial cancer patients with a

discordant pre- versus post-operative risk stratification.

European Journal of Cancer. 2017 Jun;78:82-90

77

Chapter 6 Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.

Gynecologic Oncology. 2017 Aug;146(2):380-385

97

Part III: Encouraging individualization of care for patients with endometrial cancer Chapter 7 POLE proofreading mutations elicit an anti-tumor immune response in

endometrial cancer.

Clinical Cancer Research. 2015 Jul 15;21(14):3347-55

121

Chapter 8 Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Oncoimmunology. 2016 Dec 9;6(2):e1264565

(7)

Chapter 9 Summary 183

Chapter 10 Nederlandse samenvatting voor de leek 189

Chapter 11 Discussion and perspectives 195

Appendices: List of contributing authors and affiliations 209

(8)
(9)

Referenties

GERELATEERDE DOCUMENTEN

Within the selection of patients with advanced stage disease (FIGO IIIC-IV) who underwent complete/ optimal cytoreduction, patients receiving PCS+ACT had a 5-year overall survival

The maximal referral interval is 7 days. The data that was needed to calculate the referral interval was available for 218 indirectly referred patients. Although the median

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial):

Multivariable analysis in which surgical staging was defined as removal of at least 10 lymph nodes during surgery confirmed the presence of unfavorable survival in the pre-operative

Percentage of low, low-intermediate, high-intermediate and high risk endometrial cancer patients treated according to adjuvant therapy guidelines per oncologic region

By complementary analysis of two independent series totaling nearly four hundred patients, and including over sixty POLE-proofreading mutant tumors, we have shown that POLE-mutant

In conclusion, the presence of enhanced immune infiltration, particularly high numbers of PD-1 and PD-L1 positive cells, in highly mutated, neoantigen-rich POLE-mutant and

The rise in the annual case load of hospitals treating patients with advanced stage ovarian cancer due to centralization of care, in combination with the expanding proportion of